Orchard Therapeutics’ $150 Million Series C Round Funding

Paolo Bossi

Cooley advised Orchard Therapeutics on its oversubscribed $150 million Series C financing. According to Orchard, the funding will be used to progress its three most advanced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now